제이투케이바이오

420570KOSDAQ

60.3 / 100

Reference Date: 2026-09-08

Financial Score22.0 / 40

News Sentiment21.3 / 25

Momentum7.0 / 20

Disclosure10.0 / 15

AI Analysis: the debt ratio is very low with excellent financial health but Operating Profit is on a declining trend. Declined 11.6% over the past month, and news sentiment is neutral.

Company InformationBased on 2025 Annual Report

Business Overview

JtK Bio, established in 2017, is a company specializing in the development and sales of cosmetic raw materials based on natural substances and fermented microorganisms. It operates two main business segments: cosmetic material production (including natural, bio, and solvent-based materials) and clinical services (such as efficacy evaluation through human trials).

Number of Employees

59people

Average Salary

56.2M KRW

Score Calculation Basis

Detailed Financial Score

PER

19.89Industry Average 15.003.0Point

Higher than industry avg (caution)

PBR

1.58Industry Average 1.202.5Point

Higher than industry avg (caution)

ROE

8.21Industry Average 8.004.0Point

In line with industry avg

Debt Ratio

3.55Industry Average 100.008.0Point

Half of industry avg (excellent)

Trend 2023~20254.5 / 10 points

Revenue Growth Rate

2.0 / 3

Avg ▲7.9% (2-year basis)

Operating Profit Growth Rate

0.0 / 3

Avg ▼27.4% (2-year basis)

ROE Trend

2.5 / 4

Avg ROE 11.6% (declining, 3yr)

Detailed News Sentiment

1 totalPositive 1Neutral 0Negative 0Average Sentiment Score 85

Positive
제이투케이바이오, 2Q 매출 156억 ‘분기 최대’…영업익 286%↑
제이투케이바이오의 2분기 매출이 분기 최대치를 기록하며 성장과 수익성 개선이 동시에 이루어졌다.

Detailed Momentum

52-week position5.0Point

52w mid range (43%)

Current 9,130Won52-week high 12,00052-week low 6,950

1-month return1.0Point

1m -11.62% (falling)

Volume trend1.0Point

Volume decreasing

Detailed Disclosure

2 totalPositive 0Neutral 2Negative 0

Neutral임원ㆍ주요주주특정증권등소유상황보고서2026-08-26
Neutral반기보고서 (2026.06)2026-08-12